Gene · 3384
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of Blastocyst Complementation and Omics Allows Fast Evaluation of Human Pathogenic Mutations in Mice. | Am J Respir Cell Mol Biol | 2026 | 42814875 | PubTator, text mining | PubMed |
| Clerodendrum japonicum Extract Suppresses the Pathogenicity of Rheumatoid Arthritis Fibroblast-Like Synoviocytes by Inhibiting METTL3-Mediated ICAM2 mRNA Methylation. | Cell Biochem Funct | 2026 | 42764683 | PubTator, text mining | PubMed |
| A Cross-Sectional Exploratory Study of Endothelial Biomarkers in Non-Obese Women with and Without Polyendocrine Metabolic Ovarian Syndrome. | Int J Mol Sci | 2026 | 42737559 | PubTator, text mining | PubMed |
| Cycloechinulin inhibits breast cancer progression via the SGOL2/METTL3/ICAM2 signaling axis and suppresses the growth of breast cancer patient-derived organoids. | Cell Signal | 2026 | 42697347 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals cellular heterogeneity and neoadjuvant chemotherapy response signatures in triple-negative breast cancer. | Front Oncol | 2026 | 42687923 | PubTator, text mining | PubMed |
| CircDOPEY2 promotes prostate cancer metastasis via inhibiting heterogeneous nuclear ribonucleoprotein M ubiquitination to stabilize intercellular adhesion molecule 2 mRNA. | J Pharmacol Exp Ther | 2026 | 42664534 | PubTator, text mining | PubMed |
| Visualization of new vessel formation during venous thrombus organization using genetic fate mapping. | Res Pract Thromb Haemost | 2026 | 42656861 | PubTator, text mining | PubMed |
| A Coordinated Adhesion-Molecule Activation Profile in Pediatric Sepsis: A Prospective Cohort Study from Vietnam. | Pediatr Rep | 2026 | 42347075 | PubTator, text mining | PubMed |
| Investigating Immune Microenvironment of Inflammatory Bowel Disease and the Mitochondrial Metabolism-Related Molecular Mechanisms: Combining a Multiomics Approach and Experimental Validation. | OMICS | 2026 | 42295138 | PubTator, text mining | PubMed |
| Integrated single-cell transcriptomic analysis identifies PF4 + /PPBP + megakaryocyte-like granulocytes associated with immune dysregulation in autoimmune diseases. | Biochem Biophys Rep | 2026 | 42180183 | PubTator, text mining | PubMed |
| ICAM2 promotes endocrine resistance via dynein-mediated OXPHOS activation in ER-positive breast cancer. | Cell Death Dis | 2026 | 42151122 | PubTator, text mining | PubMed |
| Replication-competent SIVcpz CRISPR screen identifies barriers to successful cross-species transmission. | J Virol | 2026 | 42095660 | PubTator, text mining | PubMed |
| Identification of a distinct cluster of LY6E+ macrophages in esophageal squamous cell carcinoma: functional phenotype, spatial interaction, and prognostic significance. | Br J Cancer | 2026 | 42056379 | PubTator, text mining | PubMed |
| Microarray Analysis of Human Abdominal Aortic Aneurysm With Emphasis on Cardiovascular Genes Revealed Differentially Expressed Genes. | In Vivo | 2026 | 42049434 | PubTator, text mining | PubMed |
| Comparative whole blood late-stage transcriptomics of polysaccharide and conjugated meningococcal serogroup A vaccine reveals distinct and persistent immune signatures in murine model. | Vaccine | 2026 | 41936263 | PubTator, text mining | PubMed |
| Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma. | J Immunother Cancer | 2026 | 41912268 | PubTator, text mining | PubMed |
| RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs. | J Immunother Cancer | 2026 | 41912267 | PubTator, text mining | PubMed |
| Unveiling lactylation: A novel frontier in the pathogenesis of diabetic nephropathy (Review). | Int J Mol Med | 2026 | 41891971 | PubTator, text mining | PubMed |
| Linking first-pass reperfusion success to proteomic markers in large and medium vessel ischemic stroke: an exploratory study. | Precis Clin Med | 2026 | 41878235 | PubTator, text mining | PubMed |
| Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical response. | Cell Mol Life Sci | 2026 | 41840229 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3384/papers